Weekly Recap: HA1406 Phase III success and CSPC Innovation H1 profitTradingView·1 day ago, 06:13 PM01093+1.77%300765+2.81%
CSPC Pharma says China clears clinical trial for RSV vaccine candidate SYS 6057PUBT·Jul 31 at 04:56 AM01093+1.77%
HK Midday: Hang Seng Inches Up 0.3%; Solar Stocks Surge, Alibaba Jumps Over 6%Market Pulse·19 hours ago06865+0.45%03800-0.74%
CSPC says FDA clears CRB-701 pivotal trial in second-line oropharyngeal cancerPUBT·Jul 29 at 07:34 AMCRBP-0.56%01093+1.77%
Sino Biopharma says CDE grants breakthrough therapy status to TQB2102 for HER2-low breast cancerPUBT·17 hours ago01177+2.22%
CSPC PHARMA Marketing Application for Sirolimus for Injection AcceptedAASTOCKS News·Jul 27 at 09:07 PM01093+1.77%
CSPC PHARMA HA1406 Enteric-coated Tablets for Depression Treatment Meet Primary Endpoint in Phase III Clinical TrialAASTOCKS News·Jul 27 at 09:07 PM01093+1.77%
Morgan Stanley Remains a Buy on CSPC Pharmaceutical Group (CHJTF)Tip Ranks·Jul 28 at 07:36 PM01093+1.77%
CSPC says China NMPA accepts sirolimus albumin-bound injection filing, grants priority reviewPUBT·Jul 27 at 07:58 AM01093+1.77%300765+2.81%
CSPC PHARMA Expects Interim Consolidated Profit of Approximately RMB5.9B-6.2BAASTOCKS News·Jul 27 at 04:44 AM01093+1.77%300765+2.81%
CSPC Innovation Pharma, CSPC Pharmaceutical Group unit, forecasts H1 net profit at 1.18 billion-1.36 billion yuanPUBT·Jul 27 at 04:34 AM01093+1.77%300765+2.81%
CSPC Pharma expects H1 profit attributable to owners at RMB 5.9 billion-RMB 6.2 billionPUBT·Jul 27 at 04:32 AM01093+1.77%AZN-6.88%
CSPC Sees Profit Surge on AstraZeneca Deal and Solid Drug SalesTip Ranks·Jul 27 at 04:37 AM01093+1.77%AZN-6.88%
Nomura Cuts CSPC PHARMA TP to HKD10.31, Expects Mild Growth in 2Q Drug SalesAASTOCKS News·Jul 26 at 10:47 PM01093+1.77%
Sino Biopharmaceutical Forms Indonesia Joint Venture With Tempo ScanTip Ranks·Jul 27 at 04:11 AM01177+2.22%
